Scientific Advisory Board

Scott T. Aaronson, MD

Scott T. Aaronson, MD

Dr. Aaronson specializes in treatment-resistant affective disorders. He is a thought leader in the areas of biological psychiatry, diagnosis and the integration of somatic and psychological therapies. He is the Principal Investigator for multiple studies on the development of novel therapies for mood, anxiety and psychotic disorders. Dr. Aaronson is a valued speaker and educator and frequently lectures, regionally and […]
View Profile
Stephen V. Faraone, Ph.D

Stephen V. Faraone, Ph.D

Stephen Faraone, PhD, is a Distinguished Professor in the Departments of Psychiatry and Neuroscience & Physiology at SUNY Upstate Medical University and Director of Research for the Department of Psychiatry. He is also Senior Scientific Advisor to the Research Program Pediatric Psychopharmacology at the Massachusetts General Hospital and a lecturer at Harvard Medical School. He holds an honorary professorship at […]
View Profile
Maurizio Fava, MD

Maurizio Fava, MD

Dr. Fava is Director, Division of Clinical Research of the Massachusetts General Hospital (MGH) Research Institute, Executive Vice Chair of the Department of Psychiatry, Founder and Executive Director of the MGH Clinical Trials Network and Institute, the first academic CRO specialized in the coordination of multi-center clinical trials in psychiatry, and Associate Dean for clinical and translational research and the […]
View Profile
Anil Malhotra, MD

Anil Malhotra, MD

Dr. Malhotra is the Director of Psychiatry Research at the Zucker Hillside Hospital in Glen Oaks, NY, Professor of Psychiatry and Behavioral Sciences at the Albert Einstein College of Medicine (AECOM) in the Bronx, NY, and an Investigator at the Feinstein Institute for Medical Research in Manhasset, NY. Dr. Malhotra’s research group currently focuses on identifying the biological underpinnings of […]
View Profile
Roy H. Perlis, MD, MSc

Roy H. Perlis, MD, MSc

Dr. Perlis’ clinical work and research is focused on difficult-to-treat or treatment resistant mood disorders, including major depressive disorder and bipolar disorder. He is the author of more than 100 peer-reviewed research publications as well as numerous book chapters and reviews. His current research efforts include identifying predictors of treatment response and identifying and studying novel treatments for mood disorders. […]
View Profile
Stephen M. Stahl, MD, PhD

Stephen M. Stahl, MD, PhD

An author of over 425 articles and more than 1500 scientific presentations and abstracts, Dr. Stahl is an internationally recognized clinician, researcher and teacher in psychiatry with subspecialty expertise in psychopharmacology. Dr. Stahl has edited five books and written 25 more, including the best-selling textbook Stahl’s Essential Psychopharmacology, now in its third edition, and the best-selling clinical manual, Essential Psychopharmacology […]
View Profile
Mark A. Stein, Ph.D., ABPP

Mark A. Stein, Ph.D., ABPP

Mark A. Stein, PhD, ABPP, is the Director of PEARL Clinic/ADHD and Related Disorders Program at Seattle Children’s Hospital and an Investigator at Seattle Children’s Research Institute. He is also a Professor of Psychiatry and Behavioral Science and a Professor of Pediatrics at the University of Washington. Dr. Stein currently serves as the President of the American Professional Society of […]
View Profile